Ezarmia Tablets 50mg

Ezarmia Tablets 50mg, from Daiichi Sankyo, contains Valemetostat Tosilate (YJ code: 4291079F1026, standard: 50mg 1 tablet). This novel, potent, and selective dual inhibitor targets histone lysine methyltransferases EZH1 and EZH2. It works by preventing the methylation of histone H3 lysine 27 (H3K27), thereby altering gene expression patterns associated with cancer and decreasing proliferation of EZH1/2-expressing cancer cells.